I think the company will ultimately stay away from "proving" pain. It will be an "aid in assessing pain". It will bring consistency to pain measurement.
In my view they should never use the word "prove", and I don't think they will. They need to keep positioning it as an aid, a data capture mechanism, a triage enhancement, AI assisted pain assessment.
Its a small distinction - but prove is not a word I hope they ever use. Apologies if I sound like I'm "calling you out". Just semantics I'm sure but an important one in my view.
GIDDY up. I've only got a tiny parcel (2 weeks ago) but had to be in this - could be HUUUGE. AIMO.
Ann: $4.15M Placement to Fast-Track International Expansion, page-105
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 546666 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 129158 | 2 |
View Market Depth
| Last trade - 16.33pm 27/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable